NCT02824874 - CKD-396 Drug-drug Interaction Study(A) (CKD-396 DDI(A) P1) | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

April 30, 2016

Primary Completion Date

April 30, 2016

Study Completion Date

May 31, 2016

Conditions

Diabetes Mellitus, Type II

Interventions

DRUG

Duvie Tab. 0.5mg

Duvie Tab. 0.5mg\*1T/day for 5days, QD, PO

DRUG

Duvie Tab. 0.5mg + Januvia Tab. 100mg

Duvie Tab. 0.5mg + Januvia Tab.100mg\*1T/day for 5 dyas, QD, PO

Trial Locations (1)

Chonbuk National University Hospital, Jeonju